Pharma & Life Science

In this highly regulated sector, we assist healthcare and life science businesses, pharmaceutical companies, biotechnology companies, cosmetics and healthcare product manufacturers on a broad range of disputes involving issues of intellectual property, product liability, research and development, supply chain, distribution, contractual arrangements and financing.  

Whether the claim concerns an (exclusive) distribution agreement, a product liability claim or arises out of a merger or acquisition in the pharma industry, we guide our clients through these complex disputes irrespective of the challenges they bring, while minimizing any associated reputational and commercial risks.

Representative Experience

  • ICC arbitration between a US provider of health information technology solutions and a European industrial group arising out of the acquisition of a global business unit
  • NAI arbitration between a European biotech firm and a US pharmaceutical giant arising out of licensing and supply agreements for anticoagulants
  • ICC arbitration between two European pharmaceutical companies about the consequences of the termination of their cooperation in the production, supply and distribution of prescription oral contraceptives
  • UNCITRAL investment arbitration between two European investors and Middle Eastern State concerning an (alleged) investment in the health sector
  • Ad hoc arbitration between a European pharmaceutical major and a European State agency about the supply of mRNA vaccines